Venture Global Inc
7 nominees · 2 ballot items.
Election of seven director nominees and ratification of Ernst & Young LLP as the company’s independent registered public accounting firm for 2026.
Follow how the vote landed and what changed on Venture Global Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot2
- 1
Election of the 7 director nominees
ManagementBoard: FORElect seven individuals nominated to serve as directors until the next annual meeting or until their successors are elected or appointed.
- 2
Ratification of selection of Ernst & Young LLP as independent registered public accounting firm for 2026
ManagementBoard: FORRatify the Audit Committee’s selection of Ernst & Young LLP (EY) as the Company’s independent registered public accounting firm and PCAOB auditor for fiscal year 2026.
Nominees on the ballot7
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Allianz Asset Management GmbH | 10.1% | 251,315,622 | $4.0B |
| 2 | D. E. Shaw Co., Inc.Activist | 0.5% | 13,003,707 | $205M |
| 3 | STATE STREET CORP | 0.4% | 9,416,679 | $148M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 0.4% | 9,322,763 | $147M |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 0.4% | 9,140,412 | $144M |
| 6 | BlackRock, Inc. | 0.3% | 7,367,824 | $116M |
| 7 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.2% | 5,194,103 | $82M |
| 8 | COHEN STEERS, INC. | 0.2% | 5,008,244 | $79M |
| 9 | DEUTSCHE BANK AG\ | 0.2% | 4,687,553 | $74M |
| 10 | UBS Group AG | 0.2% | 4,453,469 | $70M |
Other Energy sector meetings6
Upcoming shareholder meetings at Venture Global Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Venture Global Inc 2026 annual meeting?
- Venture Global Inc (VG) holds its 2026 annual shareholder meeting on Wednesday, May 27, 2026.
- What is the record date for the Venture Global Inc 2026 meeting?
- The record date for the Venture Global Inc 2026 meeting is Monday, March 30, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Venture Global Inc's 2026 meeting?
- The board is presenting 7 director nominees at the Venture Global Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Venture Global Inc 2026 meeting?
- Shareholders will vote on 2 proposals at the Venture Global Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.